Tag: Trelegy ellipta

With millions of adults in the U.S. affected by chronic obstructive pulmonary disease (COPD), understanding treatment is crucial. According to recent prescribing data from pulmonologists, Albuterol and Trelegy Ellipta are consistently ranked among the two most prescribed drug medications for COPD.

In a 52-week study, Trelegy reduced the annual rate of moderate to severe COPD exacerbations by 15% compared to a dual-therapy inhaler [1.6.3]. Many users wonder, **how fast does Trelegy start working?** While it begins to work after the first dose, the most significant benefits are seen over time [1.2.1, 1.2.4].

According to the CDC, approximately 16 million Americans have been diagnosed with chronic obstructive pulmonary disease (COPD). For these individuals, understanding **what are the health benefits of taking Trelegy** can be life-changing, as it offers a once-daily treatment for both COPD and asthma that simplifies their medication regimen and provides comprehensive symptom control.